| Dr Jennifer F Jarbeau, MD | |
|
400 Bald Hill Rd Ste 524, Warwick, RI 02886-6100 | |
| (401) 737-7313 | |
| (401) 737-4207 |
| Full Name | Dr Jennifer F Jarbeau |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 26 Years |
| Location | 400 Bald Hill Rd Ste 524, Warwick, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023012572 | NPI | - | NPPES |
| 9003542 | Medicaid | RI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kent County Memorial Hospital | Warwick, RI | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Rhode Island Hospital | Providence, RI | Hospital |
| South County Hospital Inc | Wakefield, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Affinity Physicians Llc. | 0244413391 | 619 |
| Kent County Memorial Hospital | 2668377078 | 25 |
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older. DULERA is not indicated for the relief of acute bronchospasm. DULERA combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta2-agonist (formoterol fumarate).
Helminths, such as roundworms and threadworms, are rare in developed countries, where rates of Crohn's disease are high. But in developing countries where corresponding rates of the disease are low, many people carry these parasitic worms.
Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.
American Portwell Technology, Inc., a wholly owned subsidiary of Portwell, Inc., a world-leading innovator in the Industrial PC market and a Titanium member of Intel® Partner Alliance, has launched its certification-ready MEDS-P2210-P200 and MEDS-P2410-P200, battery powered all-in-one medical computer that features true-flat capacitive touchscreen, both finger and glove operated and optional hot-swappable batteries.
› Verified 1 days ago
| Entity Name | Kent County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386643294 PECOS PAC ID: 2668377078 Enrollment ID: O20040628000569 |
News Archive
Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older. DULERA is not indicated for the relief of acute bronchospasm. DULERA combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta2-agonist (formoterol fumarate).
Helminths, such as roundworms and threadworms, are rare in developed countries, where rates of Crohn's disease are high. But in developing countries where corresponding rates of the disease are low, many people carry these parasitic worms.
Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.
American Portwell Technology, Inc., a wholly owned subsidiary of Portwell, Inc., a world-leading innovator in the Industrial PC market and a Titanium member of Intel® Partner Alliance, has launched its certification-ready MEDS-P2210-P200 and MEDS-P2410-P200, battery powered all-in-one medical computer that features true-flat capacitive touchscreen, both finger and glove operated and optional hot-swappable batteries.
› Verified 1 days ago
| Entity Name | Southcoast Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137629 PECOS PAC ID: 0749171957 Enrollment ID: O20050502000716 |
News Archive
Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older. DULERA is not indicated for the relief of acute bronchospasm. DULERA combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta2-agonist (formoterol fumarate).
Helminths, such as roundworms and threadworms, are rare in developed countries, where rates of Crohn's disease are high. But in developing countries where corresponding rates of the disease are low, many people carry these parasitic worms.
Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.
American Portwell Technology, Inc., a wholly owned subsidiary of Portwell, Inc., a world-leading innovator in the Industrial PC market and a Titanium member of Intel® Partner Alliance, has launched its certification-ready MEDS-P2210-P200 and MEDS-P2410-P200, battery powered all-in-one medical computer that features true-flat capacitive touchscreen, both finger and glove operated and optional hot-swappable batteries.
› Verified 1 days ago
| Entity Name | Affinity Physicians Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184944662 PECOS PAC ID: 0244413391 Enrollment ID: O20110326000053 |
News Archive
Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older. DULERA is not indicated for the relief of acute bronchospasm. DULERA combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta2-agonist (formoterol fumarate).
Helminths, such as roundworms and threadworms, are rare in developed countries, where rates of Crohn's disease are high. But in developing countries where corresponding rates of the disease are low, many people carry these parasitic worms.
Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.
American Portwell Technology, Inc., a wholly owned subsidiary of Portwell, Inc., a world-leading innovator in the Industrial PC market and a Titanium member of Intel® Partner Alliance, has launched its certification-ready MEDS-P2210-P200 and MEDS-P2410-P200, battery powered all-in-one medical computer that features true-flat capacitive touchscreen, both finger and glove operated and optional hot-swappable batteries.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer F Jarbeau, MD 200 Mill Road, Suite 180, Fairhaven, MA 02719-5252 Ph: (508) 973-2000 | Dr Jennifer F Jarbeau, MD 400 Bald Hill Rd Ste 524, Warwick, RI 02886-6100 Ph: (401) 737-7313 |
News Archive
Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older. DULERA is not indicated for the relief of acute bronchospasm. DULERA combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta2-agonist (formoterol fumarate).
Helminths, such as roundworms and threadworms, are rare in developed countries, where rates of Crohn's disease are high. But in developing countries where corresponding rates of the disease are low, many people carry these parasitic worms.
Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.
American Portwell Technology, Inc., a wholly owned subsidiary of Portwell, Inc., a world-leading innovator in the Industrial PC market and a Titanium member of Intel® Partner Alliance, has launched its certification-ready MEDS-P2210-P200 and MEDS-P2410-P200, battery powered all-in-one medical computer that features true-flat capacitive touchscreen, both finger and glove operated and optional hot-swappable batteries.
› Verified 1 days ago
Dr. Sterling Leaf Malish, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 | |
Dr. John David Lowney, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1030 Warwick Ave, Warwick, RI 02888 Phone: 401-467-6257 Fax: 401-785-1191 | |
Dr. Christian Rene Herard, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 300 Tollgate Road, Suite 302, Warwick, RI 02886 Phone: 401-738-4014 Fax: 401-738-4090 | |
John A Gelzhiser, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 Fax: 401-736-4265 | |
Dr. Michael Seidler, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-921-9202 Fax: 401-921-9212 | |
Murli K Raman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Tollgate Rd, Brigham & Women's Cardiovascular Associates At Cne, Warwick, RI 02886 Phone: 401-681-4996 Fax: 401-921-6569 |